Dr Sheharyar Quraishi, Consultant Endocrinologist and Diabetologist explains what the current recommendations are for use of SGLT-2 inhibitors.
Transcript (auto-generated)
This transcript was generated automatically and may contain errors.
Those were drawn a few weeks ago for the use of SGLT2s in type 1 diabetes. I know people still use, I'm not sure what Donna thinks, but I think there are still for patients on SGLT2s as an unlicensed indication, well, formally, it has been advised that people should not be using SGLT2s in type 1 diabetes, and that's in line with the FDA recommendation from last year. So our current practice would dictate that we should discourage the use of SGLT2s in type 1 diabetes. you
Health Shared
Comments